The lot # was reviewed for complaint trend, nonconforming report and capa.Devices met specification prior to release and no trends were noted.Without the benefit of examination and testing, coloplast is precluded from commenting on the condition of the device or the cause of the occurrence.Should additional facts prompt us to alter or supplement any information or conclusions contained in the original mdr or in any prior supplemental reports, a follow-up report will be submitted.Coloplast has not been provided any corroborating evidence to verify the information contained in this report.Device not returned.
|
As reported to coloplast, though not verified, between (b)(6) 2015 - (b)(6) 2015: postop abdominal pain, scar tissue infection.Ems to ed to observation admission ¿ left lower abdominal/back pain x 2 days, pain over l laparoscopic port site, fever, headaches, nausea, dysuria, constipation.3-4 cm palpable mass under port site in left iliac fossa, anemia.Abdominal ultrasound ¿ anechoic fluid collection 18 x 14 x 17 mm in left iliac fossa, 13 mm moderately echogenic area in anterior uterine wall.Left port site fluid collection/ hematoma.On (b)(6) 2020 - reassured claimant that endometriosis is the cause of ongoing symptoms/problems, not restorelle/coloplast.No other adverse patient effects were reported.
|